Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,932 | -23,623 | -16,840 | -7,732 | -22,426 |
| Depreciation Amortization | 918 | 1,627 | 522 | 298 | 447 |
| Income taxes - deferred | -1,254 | -1,095 | -1,095 | -1,095 | N/A |
| Accounts receivable | -182 | -372 | -85 | 8 | N/A |
| Accounts payable and accrued liabilities | 848 | 1,843 | 1,064 | 1,247 | 741 |
| Other Working Capital | 1,982 | 936 | 194 | 340 | -1,555 |
| Other Operating Activity | 1,640 | 848 | 2,409 | 64 | 3,078 |
| Operating Cash Flow | $-25,980 | $-19,836 | $-13,831 | $-6,870 | $-19,715 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,227 | -1,061 | -535 | -44 | -918 |
| Net Acquisitions | -6,514 | -6,189 | -6,189 | -6,189 | N/A |
| Purchase Of Investment | -4,000 | -4,000 | -4,000 | N/A | -11,245 |
| Other Investing Activity | -7 | 0 | 0 | 42 | -252 |
| Investing Cash Flow | $-11,748 | $-11,250 | $-10,724 | $-6,191 | $-12,415 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,141 | 1,141 | 1,141 | N/A | -516 |
| Debt Repayment | -446 | -178 | -160 | -17 | -1,121 |
| Common Stock Issued | 22,250 | 18,415 | 18,342 | 7,597 | 46,505 |
| Common Stock Repurchased | -14 | -14 | -14 | -14 | N/A |
| Other Financing Activity | -132 | -58 | -31 | -1 | 3,000 |
| Financing Cash Flow | $22,799 | $19,306 | $19,278 | $7,565 | $47,868 |
| Beginning Cash Position | 23,772 | 23,772 | 23,772 | 23,773 | 8,034 |
| End Cash Position | 8,843 | 11,992 | 18,495 | 18,277 | 23,772 |
| Net Cash Flow | $-14,929 | $-11,780 | $-5,277 | $-5,496 | $15,738 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,980 | -19,836 | -13,831 | -6,870 | -19,715 |
| Capital Expenditure | -1,227 | -1,061 | -535 | -44 | -918 |
| Free Cash Flow | -27,207 | -20,897 | -14,366 | -6,914 | -20,633 |